Category Archives: BioUtah News
BioHive Takes the Stage at One Utah Summit
The BioHive community was featured prominently at the One Utah Summit held on May 10 at the Grand America Hotel in Salt Lake City. Speakers from the life sciences industry addressed the crowd on topics ranging from job creation and talent development to life-saving innovation and drug discovery. Tom Polen, CEO of BD, and Rob […]
Recursion Co-Founder and CEO, Chris Gibson, Awarded Governor’s Medal for Science and Technology
Recursion Co-founder and CEO, Chris Gibson, Ph.D., was honored at the One Utah Summit on May 10, receiving the Governor’s Medal for Science and Technology. Gov. Spencer Cox presented the award during the summit’s special recognition ceremony. The prestigious award commends the distinguished service, significant achievement, and positive economic impact of individuals to the state […]
Recursion CEO, Chris Gibson, Awarded Governor’s Medal for Science and Technology
Recursion CEO, Chris Gibson, Ph.D., was honored at the One Utah Summit on May 10, receiving the Governor’s Medal for Science and Technology. Gov. Spencer Cox presented the award which recognizes the distinguished service, significant achievement, and positive economic impact of individuals to the state of Utah and beyond in the fields of science and […]
IONIQ Receives Three Awards including ‘Best Medical Technology Company 2022’
IONIQ Receives Three Awards including ‘Best Medical Technology Company 2022’
BlueWind Medical Raises $64 Million to Fund Innovative Technology for Overactive Bladder (OAB) Treatment
RENOVA iStim™ implantable tibial neuromodulation device is being studied as a minimally invasive, patient-centric solution for the treatment of OAB.
New Executive Appointments Position ARUP Laboratories for Future Growth
New Executive Appointments Position ARUP Laboratories for Future Growth
First Patients Outside of U.S. Treated with TRIA Biopolymer Surgical Aortic Heart Valve in India Clinical Trial
Foldax announced that the first patients have been enrolled in the Drugs Controller General of India (DCGI)-approved clinical trial of the TRIATM biopolymer surgical aortic heart valve.
Biomerics Announces Image Guided Intervention (IGI) Division
SALT LAKE CITY, UTAH (Monday, May 2, 2022) – Biomerics, a leading vertically integrated contract manufacturer for the attractive interventional device market, announced the creation of a new division, Biomerics Image Guided Intervention (IGI). Biomerics’ IGI Division, headquartered in Salt Lake City, provides advanced image generation and processing technologies to enable real-time minimally invasive advanced […]
Genovac Acquires Platform for Antibody Screening and Characterization Services
Genovac announces that the company has acquired Carterra’s LSA platform for use in its discovery services. Genovac, previously a part of Aldevron before a management buyout in 2020, has been providing discovery services to life science researchers since 1999 from its site in Freiburg, Germany. More recently, Genovac added production, characterization, and cell line development […]
CoNextions TR Tendon Repair System receives FDA clearance
Expected to launch in May 2022, the novel system addresses traumatic tendon lacerations in the hand, wrist, and forearm CoNextions Inc., an innovator in tendon repair, is pleased to announce that CoNextions TR Tendon Repair System has received FDA 510(k) Clearance. Expected to launch in May 2022, the novel system addresses traumatic tendon lacerations in […]
Blackrock Neurotech and Phantom Neuro Partner to Enable Prosthetics and Exoskeletons that Mimic Human Movement in Real-Time
The Phantom X system uses muscle-sensing implant technology to enable greater mobility in people with orthopedic injuries. SALT LAKE CITY and AUSTIN, Texas, April 26, 2022 /PRNewswire/ — Blackrock Neurotech, an industry leader in brain-computer interface (BCI) technology, and Phantom Neuro, a recently launched neurotech startup that delivers a high accuracy system for lifelike control of robotic […]
Myriad Genetics Reports First Quarter Revenue and Reiterates Guidance for 2022
Highlights: Revenue of $164.9 million for the quarter ended March 31, 2022 Excluding revenue from divested businesses, revenue increased 11% year-over-year Diluted GAAP earnings per share (EPS) of $(0.26) and adjusted EPS of $(0.03) in the first quarter of 2022 improved by $0.26 and $0.03 year-over-year, respectively Ended the quarter with $339.2 million in cash, […]
